Literature DB >> 27957590

[Inclusion of oxaliplatin in the multimodal treatment of locally advanced rectal cancer].

Claus Rödel1, Emmanouil Fokas2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27957590     DOI： 10.1007/s00066-016-1090-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  7 in total

1.  Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.

Authors:  Claus Rödel; Ullrich Graeven; Rainer Fietkau; Werner Hohenberger; Torsten Hothorn; Dirk Arnold; Ralf-Dieter Hofheinz; Michael Ghadimi; Hendrik A Wolff; Marga Lang-Welzenbach; Hans-Rudolf Raab; Christian Wittekind; Philipp Ströbel; Ludger Staib; Martin Wilhelm; Gerhard G Grabenbauer; Hans Hoffmanns; Fritz Lindemann; Anke Schlenska-Lange; Gunnar Folprecht; Rolf Sauer; Torsten Liersch
Journal:  Lancet Oncol       Date:  2015-07-15       Impact factor: 41.316

2.  Fluorouracil-based preoperative chemoradiotherapy with or without oxaliplatin for stage II/III rectal cancer: a 3-year follow-up study.

Authors:  Dexin Jiao; Rui Zhang; Zhiqiang Gong; Fang Liu; Yue Chen; Qinrui Yu; Liping Sun; Hongyan Duan; Shendong Zhu; Fei Liu; Jian Wang; Jianhui Jia
Journal:  Chin J Cancer Res       Date:  2015-12       Impact factor: 5.087

3.  Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial.

Authors:  Yanhong Deng; Pan Chi; Ping Lan; Lei Wang; Weiqing Chen; Long Cui; Daoda Chen; Jie Cao; Hongbo Wei; Xiang Peng; Zonghai Huang; Guanfu Cai; Ren Zhao; Zhongcheng Huang; Lin Xu; Hongfeng Zhou; Yisheng Wei; Hao Zhang; Jian Zheng; Yan Huang; Zhiyang Zhou; Yue Cai; Liang Kang; Meijin Huang; Junsheng Peng; Donglin Ren; Jianping Wang
Journal:  J Clin Oncol       Date:  2016-08-01       Impact factor: 44.544

4.  Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.

Authors:  Carlo Aschele; Luca Cionini; Sara Lonardi; Carmine Pinto; Stefano Cordio; Gerardo Rosati; Salvatore Artale; Angiolo Tagliagambe; Giovanni Ambrosini; Paola Rosetti; Andrea Bonetti; Maria Emanuela Negru; Maria Chiara Tronconi; Gabriele Luppi; Giovanni Silvano; Domenico Cristiano Corsi; Anna Maria Bochicchio; Germana Chiaulon; Maurizio Gallo; Luca Boni
Journal:  J Clin Oncol       Date:  2011-05-23       Impact factor: 44.544

5.  Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.

Authors:  Carmen J Allegra; Greg Yothers; Michael J O'Connell; Robert W Beart; Timothy F Wozniak; Henry C Pitot; Anthony F Shields; Jerome C Landry; David P Ryan; Amit Arora; Lisa S Evans; Nathan Bahary; Gamini Soori; Janice F Eakle; John M Robertson; Dennis F Moore; Michael R Mullane; Benjamin T Marchello; Patrick J Ward; Saima Sharif; Mark S Roh; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2015-09-14       Impact factor: 13.506

6.  Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer.

Authors:  Jean-Pierre Gérard; David Azria; Sophie Gourgou-Bourgade; Isabelle Martel-Lafay; Christophe Hennequin; Pierre-Luc Etienne; Véronique Vendrely; Eric François; Guy de La Roche; Olivier Bouché; Xavier Mirabel; Bernard Denis; Laurent Mineur; Jean-François Berdah; Marc-André Mahé; Yves Bécouarn; Olivier Dupuis; Gérard Lledo; Jean-François Seitz; Laurent Bedenne; Béata Juzyna; Thierry Conroy
Journal:  J Clin Oncol       Date:  2012-10-29       Impact factor: 44.544

Review 7.  Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysis.

Authors:  Yong-Jing Yang; Ling Cao; Zhi-Wen Li; Ling Zhao; Hong-Fen Wu; Dan Yue; Jin-Lei Yang; Zhi-Rui Zhou; Shi-Xin Liu
Journal:  Oncotarget       Date:  2016-07-19
  7 in total
  1 in total

1.  The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.

Authors:  Tarkan Jäger; Daniel Neureiter; Mohammad Fallaha; Philipp Schredl; Tobias Kiesslich; Romana Urbas; Eckhard Klieser; Josef Holzinger; Felix Sedlmayer; Klaus Emmanuel; Adam Dinnewitzer
Journal:  Strahlenther Onkol       Date:  2018-08-01       Impact factor: 3.621
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.